Answers are grounded in this paper and cite their sources.
Piezoelectric sonodynamic therapy (SDT) holds great promise in the treatment of solid tumors, but its efficacy is severely limited by the rapid recombination of charge carriers, the immunosuppressive tumor microenvironment (TME), and the protective mitophagy clearance of tumor cells. Herein, we constructed a single‐atom piezoelectric nanoplatform (HCQ@Ru@Cu 3 VS 4‐x ) that synergizes multiple stress induction with damage clearance blockade. Through defect engineering, ruthenium single atoms (Ru SA ) are precisely anchored on the sulfur vacancies (S V ) of Cu 3 VS 4‐x , establishing a strong metal‐support interaction (SMSI). This structure not only reduces the bandgap and amplifies the ultrasound‐triggered piezoelectric polarization effect to achieve cascade amplification of ROS production, but also provides multiple enzyme‐mimic activities for TME remodeling. Moreover, the tumor‐specific release of Cu ions triggers cuproptosis‐mediated metabolic stress, while the co‐loaded hydroxychloroquine (HCQ) specifically disrupts lysosomal acidification thereby blocking the mitophagy clearance pathway of damaged mitochondria. This lethal combination of mitochondrial damage amplification and restricted clearance pathways leads to irreversible mitochondrial dysfunction and triggers immunogenic cell death (ICD). In vivo evaluations demonstrate that this synergistic paradigm can not only eradicate primary tumors but also elicit a potent abscopal effect to suppress distant metastasis, providing a novel paradigm for overcoming immune tolerance and therapeutic resistance in complex solid tumors.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: